Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Reunion Neuroscience Inc
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Between 18 and 55 years of age (inclusive), and a body mass index of 18-34 kg/m2.
Willing to take a drug with psychoactive properties
If female and of childbearing potential, agrees to use an acceptable method of birth control and is not planning to become pregnant before, during or within 90 days after the last dose of the study drug.
If male, must agree to use condom with spermicide during and up to 90 days after discharge."
Must agree to refrain from sperm or egg donation until 120 days post discharge.
Able to understand and adhere to study schedule and requirements and willing to sign an ICF
In good general health as determined by medical history, clinical laboratory test results, vital sign measurements, 12-lead ECG results, and physical examination findings at screening
Agrees to not participate in other research studies involving investigational medication or medical devices for the duration of the study
You may not be if
Active or medical history of bipolar disorder, schizophrenia, schizoaffective disorder, psychotic disorder and/or borderline personality disorder, or first-degree family history of psychosis or bipolar disorder.
Medical condition or other concomitant condition or history rendering unsuitability for the study
Has used or intends to use prohibited medications
Has a known sensitivity or intolerance to hallucinogenic or psychedelic substances, or potential rescue medications
Has participated in another clinical study within 30 days and/or with a \[14C\] labeled study drug within 1 year prior to enrolling.
Is pregnant or has a female partner who is pregnant
Clareo Health | RE104 Radiolabeled Mass Balance (hAME) Study
